There is insufficient evidence to support use of the live attenuated influenza vaccine in children under the age of 2.
Children between 6 months and 2 years of age should only receive the trivalent inactivated influenza vaccine.
Children 6 months or older with evidence of, or a history of, reactive airways disease should not receive the live attenuated influenza vaccine.